Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cHL скачать в хорошем качестве

Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cHL

(IN FRENCH) In this video capsule, Dr Christian Lemieux summarizes a paper by Dr Abramson, et al. on the management of Peripheral Neuropathy Associated with Brentuximab Vedotin in the Frontline Treatment of classical Hodgkin Lymphoma. Dr Lemieux is a Hematologist at the Centre hospitalier universitair de Québec-Université Laval. He is also a member of the immunocellular therapy network fellowship program at Université Laval. Dr Lemieuz provides his perspective on the management of PN and puts it in the context of Canadian clinical practice. This podcast episode was sponsored by Pfizer Canada Inc. If you enjoyed our podcast episode, please review and subscribe. For other medical education content, visit our website at: https://www.impactmedicom.com (https://www.youtube.com/redirect?even...) (https://www.impactmedicom.com/) (https://www.youtube.com/redirect?even...) .